RAD21 and acute myeloid leukemia: This study is the first one that investigates whether RAD21 methylation has a possible implication in AML pathogenesis and AML chromosomal abnormalities, correlating the methylation data with patient’s clinicopathological characteristics and cytogenetic profile.